PharmaCorp Rx Inc. (TSXV: PCRX)
Canada flag Canada · Delayed Price · Currency is CAD
0.500
-0.040 (-7.41%)
Dec 20, 2024, 3:58 PM EST

PharmaCorp Rx Ratios and Metrics

Millions CAD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2023 FY 2022 FY 2021
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
59412-
Market Cap Growth
1795.00%-64.51%--
Enterprise Value
3329-
Last Close Price
0.500.210.60-
PB Ratio
1.961.874.42-
P/TBV Ratio
3.111.874.42-
Quick Ratio
42.0048.54166.0137.20
Current Ratio
42.6250.24166.0137.98
Return on Equity (ROE)
-12.23%-18.85%-28.02%-
Return on Assets (ROA)
-7.91%-14.29%-18.85%-
Return on Capital (ROIC)
-8.16%-14.47%-19.07%-
Earnings Yield
-3.40%-11.05%-4.31%-
FCF Yield
-2.19%-12.20%-1.00%-
Buyback Yield / Dilution
-476.74%-1.39%-23.69%-
Total Shareholder Return
-476.74%-1.39%-23.69%-
Source: S&P Capital IQ. Standard template. Financial Sources.